|Articles|April 11, 2020

OncLive Saturday Spotlight: A Morning With NYU Langone Perlmutter Cancer Center

This week we have collaborated with NYU Langone Health to highlight important topics facing oncologists today. Join us on Saturday, May 9, 2020 at 11 AM EDT.

Date/Time: Sat. May 9, 2020 at 11 AM EDT

The OncLive^® Saturday Spotlight webinars feature a panel of top physicians from one of our nation’s leading institutions. This week we have collaborated with NYU Langone Health to highlight important topics facing oncologists today.

Click here to register today!

Course Objectives:

Protecting Our Cancer Center — Screening at the Door
Caring For Cancer When the OR is Closed
Immunotherapy Concerns in A COVID World
Radiation Therapy for COVID Infected Patients — Ethical and Practical Considerations
Hematologic Malignancy in the COVID-19 Pandemic
What Everyone Wants in A COVID World — Convalescent Plasma: Trials & Tribulations
Therapeutic Anticoagulation for COVID-19 Disease
Final Analysis — Findings at COVID Autopsy
Q & A

Speakers:

Clinical Associate Professor, Department of Medicine; Chief, Oncology/Hematology, Perlmutter Cancer Center at NYU Winthrop

Jay and Isabel Fine Professor of Oncology, Department of Medicine; Professor, Department of Urology; Section Chief, Medical Oncology, Perlmutter Cancer Center; Associate Director, Cancer Services at Perlmutter Cancer Center

Professor, Department of Medicine; Chief, Hematology and Medical Oncology Inpatient Service, at Tisch Hospital; Section Chief, Hematology at Perlmutter Cancer Center

Clinical Assistant Professor, Department of Medicine; Medical director, breast program at Perlmutter Cancer Center of NYU Winthrop

Assistant Professor, Department of Medicine; Lung Cancer Center at Perlmutter Cancer Center

Professor, Department of Radiation Oncology; Anita Steckler and Joseph Steckler Chair, Radiation Oncology; Senior leader at Perlmutter Cancer Center

Clinical Assistant Professor, Department of Medicine at Perlmutter Cancer Center of NYU Winthrop

Associate Professor, Department of Pathology; Assistant Dean, Curriculum; Director, Integrated Anatomy, Histology and Pathology; Vice Chair, Patholog at, NYU Winthrop Hospital

In Association With:

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

OncLive Saturday Spotlight: A Morning With NYU Langone Perlmutter Cancer Center

Newsletter

Related Content

Roswell Park Team Exploring Promising Biomarker for Tracking Breast Cancer Response to CDK4/6 Therapy

FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma

Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer

Long-Term Epcoritamab Data Show Durable Responses and Confirmed Safety in LBCL: With Tycel Phillips, MD

Northwestern Medicine Surgeons Develop a Total Artificial Lung System to Keep a Patient Alive for 48 Hours After Removing Both Lungs, Enabling a Double-Lung Transplant

Latest CME

Community Oncology Connections™: Optimizing SCLC Treatment Strategies and Managing Adverse Events Across Disease Stages | South Carolina

Personalized Management in NSCLC: Strategies for Early Detection, Molecular Testing, and Targeted Therapies | Kansas

Community Oncology Connections™: Beyond Primary End Points—Digging Into Randomized and Real-World Data to Guide Challenging Treatment Decisions in HR+/HER2− Metastatic Breast Cancer | Washington State Medical Oncology Society

Personalized Management in NSCLC: Strategies for Early Detection, Molecular Testing, and Targeted Therapies | Wyoming and Montana

Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck – Post-CRT Decisions in the Locally Advanced Setting

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

Medical Crossfire® – From Diagnostic Dilemmas to Potential Treatment Breakthroughs: Exploring Novel Targets for Extrapulmonary Neuroendocrine Carcinomas

Addressing Unmet Needs in HER2+ Metastatic BTC

Community Practice Connections™: Tailored Treatment Approaches for Older Patients With Advanced HR+/HER2– Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Medical Crossfire®: Integrating Next-Generation Endocrine Targeting Therapies to Improve Outcomes for Patients With HR+/HER2- Breast Cancer

Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches

Medical Crossfire®: Precision Medicine in Glioma Treatment — Integration of Molecular Profiling to Inform Targeted Therapies

Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Personalized Management in NSCLC: Strategies for Early Detection, Molecular Testing, and Targeted Therapies | New Mexico

Community Oncology Connections™: Optimizing SCLC Treatment Strategies and Managing Adverse Events Across Disease Stages | North Carolina

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

19th Annual New York GU Cancers Congress™

From Bench to Bedside: Paradigm Shifts in HER2+ Metastatic BTC Treatment

Proactive Adverse Event Management for HER2+ BTC Treatments

A Case-Guided Discussion on Managing Immune Thrombocytopenic Purpura (ITP)

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer

Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD

Multidisciplinary Breast Cancer Experts Outline Proactive Strategies for Managing Treatment-Related Toxicities: With Neil Iyengar, MD; Heather Moore, CPP, PharmD; and Sarah Donahue, MPH, NP

Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer

Dr Spencer on First-Line Chemo Selection in Metastatic Pancreatic Adenocarcinoma